Bolt Biotherapeutics, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. 2.27%54.250.9%$2618.53m
JNJJohnson & Johnson 0.85%158.430.7%$1289.27m
MRKMerck & Co., Inc. -1.14%73.050.7%$1147.38m
BMYBristol-Myers Squibb Co. 1.38%56.181.0%$755.55m
LLYEli Lilly & Co. -1.71%243.651.1%$723.23m
ABBVAbbVie, Inc. 1.23%118.311.9%$589.16m
AZNAstraZeneca Plc -1.08%54.201.0%$290.13m
NVSNovartis AG -0.21%79.790.2%$176.21m
GSKGlaxoSmithKline Plc -0.58%41.230.2%$165.08m
DRNADicerna Pharmaceuticals, Inc. 0.08%38.150.3%$144.77m
VTRSViatris, Inc. -0.57%12.130.0%$140.56m
RPRXRoyalty Pharma Plc -3.60%37.480.1%$110.69m
RGENRepligen Corp. -2.76%261.416.7%$107.42m
BFRIBiofrontera, Inc. -20.38%4.180.0%$104.27m
PTPIPetros Pharmaceuticals, Inc. 2.24%2.650.0%$92.25m

Company Profile

Bolt Biotherapeutics, Inc. is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company was founded by Edgar G. Engleman on January 22, 2015 and is headquartered in Redwood City, CA.